Polymorphisms of N-acetyltransferase 2, glutathione S-transferase Mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis

被引:56
作者
Kim, WJ [1 ]
Lee, HL [1 ]
Lee, SC [1 ]
Kim, YT [1 ]
Kim, H [1 ]
机构
[1] Chungbuk Natl Univ, Coll Med, Dept Urol & Prevent Med, Cheongju, Chungbuk, South Korea
关键词
bladder neoplasms; polymorphism; genetics; asthma; tuberculosis;
D O I
10.1016/S0022-5347(05)67496-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We investigated whether the polymorphisms of N-acetyltransferase 2 (NAT2), glutathione S-transferase-mu (GSTM1) and glutathione S-transferase-theta (GSTT1) genes were risk factors of bladder cancer among Korean people in relation to other risk factors. Materials and Methods: In this case-control investigation of 113 patients with primary bladder cancer and 221 control subjects, we compared the association of bladder cancer with genetic polymorphisms of NAT2, GSTM1 and GSTT1, demographic characteristics, smoking status, and medical histories in a molecular epidemiological way. Results: The risk of bladder cancer was significantly increased in patients with a medical history of tuberculosis (OR 3.61, 95% CI 1.57 to 8.26) and bronchial asthma (OR 4.15, 95% CI 1.61 to 10.75), while smoking history turned out to be insignificant. GSTM1 null genotype was a significant risk factor of bladder cancer (OR 1.81, 95% CI 1.12 to 2.93). On the other hand, slow acetylator and GSTT1 genotypes were insignificant. Also, we could not find any association between GSTM1, GSTT1, slow acetylator genotypes and bladder cancer risk among smokers. The rapid acetylator, GSTM1 null and GSTT1 null genotypes with a medical history of asthma or tuberculosis combinations were significant risk factors in Korean subjects. Conclusions:Among Korean subjects, GSTM1 null genotype was a significant risk factor for bladder cancer. The reason why bronchial asthma and tuberculosis are risk factors in Korean subjects is yet unknown, but a variety of factors, including enzyme activities for detoxification, medication for these diseases and immunological background might be involved.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 22 条
  • [1] AN IMPROVED METHOD FOR GENOTYPING OF N-ACETYLTRANSFERASE POLYMORPHISM BY POLYMERASE CHAIN-REACTION
    ABE, M
    SUZUKI, T
    DEGUCHI, T
    [J]. JAPANESE JOURNAL OF HUMAN GENETICS, 1993, 38 (02): : 163 - 168
  • [2] BLACK (AIR-CURED) AND BLOND (FLUE-CURED) TOBACCO CANCER RISK .4. MOLECULAR DOSIMETRY STUDIES IMPLICATE AROMATIC-AMINES AS BLADDER CARCINOGENS
    BARTSCH, H
    MALAVEILLE, C
    FRIESEN, M
    KADLUBAR, FF
    VINEIS, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (08) : 1199 - 1207
  • [3] GENETIC RISK AND CARCINOGEN EXPOSURE - A COMMON INHERITED DEFECT OF THE CARCINOGEN-METABOLISM GENE GLUTATHIONE-S-TRANSFERASE M1 (GSTM1) THAT INCREASES SUSCEPTIBILITY TO BLADDER-CANCER
    BELL, DA
    TAYLOR, JA
    PAULSON, DF
    ROBERTSON, CN
    MOHLER, JL
    LUCIER, GW
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (14) : 1159 - 1164
  • [4] Brockmoller J, 1996, CANCER RES, V56, P3915
  • [5] CARTWRIGHT RA, 1982, LANCET, V2, P842
  • [6] Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect
    Chen, HW
    Sandler, DP
    Taylor, JA
    Shore, DL
    Liu, E
    Bloomfield, CD
    Bell, DA
    [J]. LANCET, 1996, 347 (8997) : 295 - 297
  • [7] Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers
    Deakin, M
    Elder, J
    Hendrickse, C
    Peckham, D
    Baldwin, D
    Pantin, C
    Wild, N
    Leopard, P
    Bell, DA
    Jones, P
    Duncan, H
    Brannigan, K
    Alldersea, J
    Fryer, AA
    Strange, RC
    [J]. CARCINOGENESIS, 1996, 17 (04) : 881 - 884
  • [8] CONJUGATION OF CARCINOGENS BY THETA-CLASS GLUTATHIONE S-TRANSFERASES - MECHANISMS AND RELEVANCE TO VARIATIONS IN HUMAN RISK
    GUENGERICH, FP
    THIER, R
    PERSMARK, M
    TAYLOR, JB
    PEMBLE, SE
    KETTERER, B
    [J]. PHARMACOGENETICS, 1995, 5 : S103 - S107
  • [9] ACETYLATOR GENOTYPE AND ARYLAMINE-INDUCED CARCINOGENESIS
    HEIN, DW
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) : 37 - 66
  • [10] Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk
    Katoh, T
    Inatomi, H
    Kim, H
    Yang, MH
    Matsumoto, T
    Kawamoto, T
    [J]. CANCER LETTERS, 1998, 132 (1-2) : 147 - 152